Recombinant multi-species AMIGO1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine AMIGO1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Predicted to enable potassium channel regulator activity. Predicted to be involved in several processes, including heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; homophilic cell adhesion via plasma membrane adhesion molecules; and nervous system development. Predicted to act upstream of or within positive regulation of synapse assembly. Predicted to be located in dendrite and neuronal cell body membrane. Predicted to be integral component of membrane. Predicted to colocalize with voltage-gated potassium channel complex. [provided by Alliance of Genome Resources, Apr 2022]
The Alternative Names of target: AMIGO1,Amphoterin-induced protein 1,AMIGO-1, Alivin-2,ALI2,AMIGO,AMIGO-1
Go
to AMIGO1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP0330-Ab-1/ GM-Tg-hg-IP0330-Ab-2 | Human AMIGO1 protein | Human |
GM-Tg-rg-IP0330-Ab-1/ GM-Tg-rg-IP0330-Ab-2 | Rat AMIGO1 protein | Rat |
GM-Tg-mg-IP0330-Ab-1/ GM-Tg-mg-IP0330-Ab-2 | Mouse AMIGO1 protein | Mouse |
GM-Tg-cynog-IP0330-Ab-1/ GM-Tg-cynog-IP0330-Ab-2 | Cynomolgus/Rhesus macaque AMIGO1 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP0330-Ab-1/ GM-Tg-felg-IP0330-Ab-2 | Feline AMIGO1 protein | Feline |
GM-Tg-cang-IP0330-Ab-1/ GM-Tg-cang-IP0330-Ab-2 | Canine AMIGO1 protein | Canine |
GM-Tg-bovg-IP0330-Ab-1/ GM-Tg-bovg-IP0330-Ab-2 | Bovine AMIGO1 protein | Bovine |
GM-Tg-equg-IP0330-Ab-1/ GM-Tg-equg-IP0330-Ab-2 | Equine AMIGO1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. |
GM-Tg-hg-IP0330-Ab-1/ GM-Tg-hg-IP0330-Ab-2;
GM-Tg-rg-IP0330-Ab-1/ GM-Tg-rg-IP0330-Ab-2;
GM-Tg-mg-IP0330-Ab-1/ GM-Tg-mg-IP0330-Ab-2; GM-Tg-cynog-IP0330-Ab-1/ GM-Tg-cynog-IP0330-Ab-2; GM-Tg-felg-IP0330-Ab-1/ GM-Tg-felg-IP0330-Ab-2; GM-Tg-cang-IP0330-Ab-1/ GM-Tg-cang-IP0330-Ab-2; GM-Tg-bovg-IP0330-Ab-1/ GM-Tg-bovg-IP0330-Ab-2; GM-Tg-equg-IP0330-Ab-1/ GM-Tg-equg-IP0330-Ab-2 |
Products Name | AMIGO1 protein |
Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
Target Name | AMIGO1 |
Protein Sub-location | Introcelluar Protein |
Isotypes | Recombinant protein |
Expression platform | Mammalian cell |
Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
Tag | His |
Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine AMIGO1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab
GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.